Alnylam Pharmaceuticals, Inc. Financial Ratios — ALNY Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-17.08	-37.23	-25.2	-48.05	-23.52	-30.96	-30.14	-42.67	-44.64	-29.58	-24.19	-31.47	-11.94	-6.89	6.82
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-9.8
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.39
Gross Margin (%)	100	100	100	100	100	100	100	97.59	88.6	84.16	83.4	83.73	83.02	85.62	81.64
EBITDA Margin (%)	-60.05	-81.72	-175.36	-340.75	-673.91	-868.25	-542.96	-1,067.21	-402.76	-152.99	-73.31	-71.39	-12.48	-5.35	15
Operating Margin (%)	-66.24	-95.27	-197.05	-364.34	-720.27	-900.33	-556.2	-1,087.56	-427.5	-168.09	-83.93	-75.68	-15.43	-7.87	13.51
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	46.29
Pretax Margin (%)	-69.66	-174.73	-194.88	-792.32	-705.83	-869.63	-545.95	-1,015.48	-402.85	-173.6	-100.93	-108.63	-23.71	-16.79	8.7
Profit Margin (%)	-69.66	-158.88	-189.17	-712.79	-705.83	-869.63	-545.95	-1,016.58	-403.24	-174.15	-101.01	-109.04	-24.08	-12.37	8.45
Net Income to Common Margin (%)	-69.66	-158.88	-189.17	-712.79	-705.83	-869.63	-545.95	-1,016.58	-403.24	-174.15	-101.01	-109.04	-24.08	-12.37	8.45
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.91
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	150	30	30	304	521	998	1,320	1,305	1,296	1,278
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	28	37	41	42	42	42	46
LT Debt	- -	- -	- -	- -	- -	150	30	30	276	484	957	1,278	1,264	1,254	1,233
Total Debt/EBITDA	- -	- -	- -	- -	- -	-0.37	-0.06	-0.04	-0.34	-0.69	-1.61	-1.78	-5.72	-10.78	2.29
Net Debt/EBITDA	1.41	0.94	0.64	0.44	0.65	0.11	1.26	0.49	0.62	0.4	0.23	-0.2	-0.91	-0.48	-1.17
Total Debt/EBIT	- -	- -	- -	- -	- -	-0.35	-0.06	-0.04	-0.32	-0.63	-1.41	-1.68	-4.63	-7.33	2.55
Net Debt/EBIT	1.28	0.81	0.57	0.41	0.61	0.1	1.23	0.48	0.58	0.37	0.2	-0.19	-0.74	-0.33	-1.29
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-8.92	-4.33	-4.75	-1.88	-0.85	2.21
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-9.76	-4.86	-5.21	-2.4	-1.09	1.97
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-9.8	-4.95	-5.03	-2.33	-1.25	1.99
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	84	143	156	121	142	253
Common Equity/Total Assets	-142.09	-176.16	-141.63	-88.54	-89.86	-131.13	-107.62	-180.34	-155.56	-134.55	-149.23	-185.21	-182.99	-171.85	-134.93
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	16.3	1.7	2.3	19.19	47.66	162.71	- -	- -	1,869.43	156.22
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-9.96	-1.42	-1.07	-8.07	-11.92	-21.56	-24.36	-22.16	-20.94	-22.73
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	11.88	1.5	1.91	11.53	14.22	26.27	36.04	33	29.58	24.82
Total Debt/Equity (%)	- -	- -	- -	- -	- -	16.3	1.7	2.3	21.12	51.29	169.6	-834.42	-591.63	1,931.86	161.99
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-9.96	-1.42	-1.07	-8.88	-12.83	-22.47	-25.16	-22.89	-21.64	-23.57
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	11.88	1.5	1.91	12.69	15.3	27.38	37.23	34.08	30.57	25.74
Net Debt to Equity	-59.52	-38.35	-19.67	-8.03	-14.3	-4.74	-34.84	-29.97	-38.03	-30.04	-24.53	-95.15	-94.31	86.74	-82.3
Net Debt/Capital (%)	14.92	9.21	8.2	7.29	12.68	2.57	22.28	12.08	13.79	6.7	2.74	-2.46	-3.19	-0.84	9.17
EBITDA	-50	-55	-83	-172	-277	-409	-488	-799	-885	-754	-619	-741	-228	-120	557
EBITDA-CapEx	-51	-63	-87	-181	-290	-474	-592	-926	-1,025	-824	-695	-813	-290	-154	499
Operating Income (Loss)	-55	-64	-93	-184	-296	-425	-500	-815	-939	-828	-709	-785	-282	-177	502

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.81	2.54	4.56	7.31	17.4	4.76	11.72	6.04	4.36	3.2	3.5	2.86	2.52	2.27	1.98
Current Ratio	1.88	2.6	4.72	7.83	17.8	5.1	12.23	6.69	4.87	4.47	4.04	3.51	3.08	2.78	2.76
Quick Ratio	1.83	2.54	4.64	7.73	17.53	4.94	11.96	6.14	4.48	4.23	3.79	3.16	2.86	2.61	2.51
CFO/Avg Current Liab	-0.95	-1.79	-1.34	-2.22	-2.4	-3.18	-2.77	-3.48	-1.05	-1.31	-1	-0.74	0.12	-0.01	0.4
Common Equity/Total Assets	-142.09	-176.16	-141.63	-88.54	-89.86	-131.13	-107.62	-180.34	-155.56	-134.55	-149.23	-185.21	-182.99	-171.85	-134.93
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	16.3	1.7	2.3	19.19	47.66	162.71	- -	- -	1,869.43	156.22
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-9.96	-1.42	-1.07	-8.07	-11.92	-21.56	-24.36	-22.16	-20.94	-22.73
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	11.88	1.5	1.91	11.53	14.22	26.27	36.04	33	29.58	24.82
Total Debt/Equity (%)	- -	- -	- -	- -	- -	16.3	1.7	2.3	21.12	51.29	169.6	-834.42	-591.63	1,931.86	161.99
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-9.96	-1.42	-1.07	-8.88	-12.83	-22.47	-25.16	-22.89	-21.64	-23.57
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	11.88	1.5	1.91	12.69	15.3	27.38	37.23	34.08	30.57	25.74
CFO/Total Liabilities	-53.12	-75.33	-45.72	-115.57	-155.29	-89.82	-167.67	-206.21	-29.11	-25.72	-21	-14.61	2.57	-0.2	12.55
CFO/CapEx	-67.44	-13.85	-17.14	-18.48	-14.61	-4.77	-3.67	-4.43	-1.99	-8.74	-8.4	-7.51	1.67	-0.24	8.93
Altman's Z-Score	-0.77	0.94	13.78	29.13	37.92	3.22	28.92	12.72	5.2	1.92	2.14	2.3	1.84	2.9	7.3

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	33.65	84.89	21.68	2.29	1.7	2.98	3.14	2.84	7.11	6.78	5.61	4.75	6.46	6.13	6.28
Days Sales Outstanding	10.85	4.3	16.84	159.49	214.2	122.41	116.38	128.55	51.3	53.85	65.06	76.79	56.47	59.51	58.13
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	0.15	0.62	1.19	1.73	1.57	2.85	3.86	8.46
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	2,437.52	585.58	307.59	210.4	232.78	128.23	94.62	43.15
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	0.59	1.05	1.9	2.41	2.47	3.52	4.35	6.72
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	621.24	348.79	191.81	151.24	148.06	103.6	83.99	54.3
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	1,944.82	288.09	169.63	124.21	161.51	81.1	70.13	46.98
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	-2,308.97	-534.28	-253.74	-145.33	-155.98	-71.76	-35.11	14.97
Inventories	- -	- -	- -	- -	- -	- -	- -	24	56	75	86	129	89	79	83
Raw Materials	- -	- -	- -	- -	- -	- -	- -	9	15	63	15	22	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	15	38	16	101	114	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	3	13	7	26	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	89	79	83

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	346	918	3,958	7,205	7,907	3,205	11,505	7,334	12,584	14,945	20,087	28,919	23,908	30,038	52,094
- Cash & Cash Equivalents	70	51	53	75	181	194	645	420	547	497	820	866	813	966	1,657
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	150	30	30	304	521	998	1,320	1,305	1,296	1,278
Enterprise Value	199	795	3,712	6,508	6,826	2,728	9,844	6,280	11,352	13,592	18,649	28,047	22,774	28,639	50,464
Total Capital	-401	-506	-596	-956	-1,246	-1,506	-2,117	-2,810	-3,422	-4,063	-4,439	-5,248	-5,703	-5,990	-5,423
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-9.96	-1.42	-1.07	-8.88	-12.83	-22.47	-25.16	-22.89	-21.64	-23.57
Total Debt / EV	- -	- -	- -	- -	- -	0.05	- -	- -	0.03	0.04	0.05	0.05	0.06	0.05	0.03
EV/Sales	2.41	11.91	78.7	128.72	166.11	57.85	109.49	83.83	51.66	27.58	22.09	27.04	12.46	12.74	13.59
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	90.56
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	100.61
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	100.21	297.55	65.59
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	78.68	219.41	60.94
Diluted Market Cap	346	918	3,958	7,205	7,907	3,205	11,505	7,334	12,584	14,945	20,087	28,919	23,908	30,038	53,557
Diluted Enterprise Value	275	866	3,905	7,130	7,726	3,161	10,890	6,944	12,341	14,969	20,265	29,373	24,401	30,367	53,178
EV per Share	4.7	15.81	60.31	87.62	81.28	31.87	108.71	62.43	103.89	118.2	157.44	230.48	182.33	224.35	385.21
TTM Sales	83	67	47	51	41	47	90	75	220	493	844	1,037	1,828	2,248	3,714
TTM EBITDA	-50	-55	-83	-172	-277	-409	-488	-799	-885	-754	-619	-741	-228	-120	557
TTM Operating Income	-55	-64	-93	-184	-296	-425	-500	-815	-939	-828	-709	-785	-282	-177	502
TTM Cash Flow to Firm	-87	-116	-69	-166	-189	-308	-383	-563	-278	-530	-499	-385	227	96	769
TTM Free Cash Flow to Firm	-86	-107	-65	-157	-176	-243	-279	-436	-138	-460	-422	-313	289	131	828

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-4.03	-8.56	-61.22	-45.99	-44.88	-13.18	-41.3	-16.83	-91.01	-27.44	-35.53	-61.63	143.71	1,156.85	91.9
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	100.61
Enterprise Value	199	795	3,712	6,508	6,826	2,728	9,844	6,280	11,352	13,592	18,649	28,047	22,774	28,639	50,464
Low Price	5.88	8.33	18.61	47.03	71.14	31.38	35.98	60.27	65.81	84.97	124	117.58	148.1	141.98	205.87
EV/Sales	2.41	11.91	78.7	128.72	166.11	57.85	109.49	83.83	51.66	27.58	22.09	27.04	12.46	12.74	13.59
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	90.56
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	166.04
Price/Earnings Average	-6.45	-6.8	-27.68	-15.15	-30.74	-12.62	-14.84	-13.36	-10.46	-17.63	-23.32	-18.81	-54.58	-97.64	145.24
Price/Earnings High	-9.08	-10.14	-46.89	-23.2	-40.54	-20.45	-27.23	-20.34	-15.5	-22.42	-29.45	-26.14	-68.77	-139.69	206.92
Price/Earnings Low	-4.32	-3.95	-12.84	-9.69	-20.6	-6.55	-6.64	-7.96	-8.11	-11.38	-17.22	-12.65	-42.02	-65.16	85.96
Price/Book Value	-0.86	-1.81	-6.64	-7.54	-6.35	-1.94	-5.36	-2.58	-3.38	-3.26	-3.69	-4.4	-3.41	-4.12	-7.77
Price/Book Value Average	-0.93	-1.42	-4.15	-5.71	-7.16	-3.13	-3.39	-3.58	-2.49	-3.3	-3.66	-3.24	-3.43	-3.73	-6.8
Price/Book Value High	-1.31	-2.12	-7.02	-8.75	-9.44	-5.07	-6.23	-5.45	-3.69	-4.2	-4.62	-4.5	-4.32	-5.33	-9.69
Price/Book Value Low	-0.62	-0.83	-1.92	-3.65	-4.8	-1.62	-1.52	-2.13	-1.93	-2.13	-2.7	-2.18	-2.64	-2.49	-4.02
Price/Tangible Book Value	2.94	6.85	14.64	7.7	6.25	3.48	6.51	5.63	8.75	14.71	34.15	-182.78	-108.36	447.73	66.01
Price/Tangible Book Value Average	3.16	5.38	9.14	5.83	7.05	5.63	4.12	7.82	6.44	14.89	33.81	-134.47	-108.91	404.83	57.74
Price/Tangible Book Value High	4.45	8.02	15.48	8.93	9.3	9.12	7.57	11.9	9.55	18.93	42.69	-186.87	-137.22	579.17	82.26
Price/Tangible Book Value Low	2.12	3.12	4.24	3.73	4.72	2.92	1.84	4.66	5	9.61	24.97	-90.43	-83.84	270.15	34.17
Price/Sales	4.18	13.75	83.91	142.5	192.4	67.96	127.96	97.91	57.26	30.32	23.79	27.88	13.08	13.36	14.03
Price/Sales Average	4.49	10.81	52.36	107.99	216.98	109.77	80.99	135.86	42.18	30.7	23.55	20.51	13.14	12.08	12.27
Price/Sales High	6.32	16.11	88.7	165.37	286.13	177.88	148.68	206.78	62.51	39.04	29.74	28.5	16.56	17.28	17.48
Price/Sales Low	3.01	6.28	24.29	69.09	145.39	56.96	36.24	80.93	32.72	19.82	17.4	13.79	10.12	8.06	7.26
Price/Cash Flow	-3.97	-7.94	-57.64	-43.5	-41.81	-10.42	-30.06	-13.04	-45.2	-24.3	-31.3	-53.43	229.54	-3,613.76	99.4
Price/Cash Flow Average	-4.27	-6.24	-35.97	-32.96	-47.15	-16.82	-19.02	-18.09	-33.29	-24.6	-30.99	-39.31	230.71	-3,267.5	86.95
Price/Cash Flow High	-6.01	-9.3	-60.94	-50.48	-62.17	-27.26	-34.92	-27.53	-49.34	-31.29	-39.13	-54.62	290.68	-4,674.65	123.87
Price/Cash Flow Low	-2.86	-3.62	-16.68	-21.09	-31.59	-8.73	-8.51	-10.78	-25.83	-15.89	-22.89	-26.43	177.6	-2,180.45	51.46
Price/Free Cash Flow Average	-4.33	-6.72	-38.2	-34.85	-50.61	-21.29	-26.14	-23.36	-67.04	-27.78	-35.18	-45.35	144.44	1,046	80.39
Price/Free Cash Flow High	-6.1	-10.02	-64.71	-53.37	-66.74	-34.5	-47.99	-35.55	-99.35	-35.33	-44.42	-63.01	181.98	1,496.46	114.53
Price/Free Cash Flow Low	-2.91	-3.91	-17.72	-22.3	-33.91	-11.05	-11.7	-13.91	-52	-17.94	-25.98	-30.49	111.19	698.01	47.58
EV/Sales Average	3.64	10.04	51.23	106.51	212.58	108.85	74.15	130.65	41.08	30.75	23.76	20.95	13.41	12.23	12.17
EV/Sales High	5.48	15.34	87.57	163.89	281.72	176.95	141.84	201.57	61.4	39.09	29.95	28.94	16.83	17.43	17.38
EV/Sales Low	2.16	5.51	23.16	67.6	140.99	56.03	29.39	75.73	31.61	19.87	17.61	14.23	10.39	8.21	7.16
EV/EBITDA Average	-6.06	-12.29	-29.22	-31.26	-31.54	-12.54	-13.66	-12.24	-10.2	-20.1	-32.42	-29.34	-107.5	-228.67	81.1
EV/EBITDA High	-9.12	-18.77	-49.94	-48.1	-41.8	-20.38	-26.12	-18.89	-15.25	-25.55	-40.86	-40.54	-134.88	-325.96	115.82
EV/EBITDA Low	-3.6	-6.74	-13.21	-19.84	-20.92	-6.45	-5.41	-7.1	-7.85	-12.99	-24.02	-19.93	-83.25	-153.5	47.72
EV/EBIT Average	-5.5	-10.54	-26	-29.23	-29.51	-12.09	-13.33	-12.01	-9.61	-18.29	-28.31	-27.68	-86.91	-155.41	90.1
EV/EBIT High	-8.27	-16.1	-44.44	-44.98	-39.11	-19.65	-25.5	-18.53	-14.36	-23.25	-35.69	-38.24	-109.04	-221.53	128.67
EV/EBIT Low	-3.27	-5.78	-11.75	-18.56	-19.57	-6.22	-5.28	-6.96	-7.4	-11.82	-20.98	-18.8	-67.3	-104.32	53.01
Last Price	8.15	18.25	64.3	97	94.14	37.44	127.05	72.91	115.17	129.97	169.58	237.65	191.41	235.31	397.65
High Price	12.34	21.38	67.97	112.57	140	98	147.63	153.99	125.72	167.33	212	242.97	242.39	304.39	495.55
Enterprise Value Average	301	670	2,417	5,385	8,737	5,133	6,667	9,787	9,026	15,155	20,064	21,731	24,523	27,489	45,190
Enterprise Value High	453	1,024	4,130	8,286	11,578	8,345	12,753	15,099	13,493	19,265	25,289	30,021	30,769	39,185	64,540
Enterprise Value Low	179	367	1,092	3,418	5,794	2,642	2,643	5,672	6,947	9,795	14,866	14,762	18,991	18,454	26,591

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	43	52	64	77	85	86	100	101	112	116	120	124	126	129	132
Diluted Weighted Avg Shares	42	50	62	74	84	86	91	101	109	115	118	122	125	128	135
Basic Weighted Avg Shares	42	50	62	74	84	86	91	101	109	115	118	122	125	128	131
Revenue per Share	1.95	1.33	0.77	0.68	0.49	0.55	0.99	0.74	2.01	4.29	7.13	8.53	14.64	17.61	28.35
EBITDA per Share	-1.17	-1.08	-1.34	-2.32	-3.3	-4.78	-5.39	-7.95	-8.1	-6.56	-5.23	-6.09	-1.83	-0.94	4.25
Operating Income per Share	-1.29	-1.26	-1.51	-2.48	-3.52	-4.96	-5.52	-8.1	-8.6	-7.2	-5.98	-6.45	-2.26	-1.39	3.83
Basic EPS, GAAP	-1.36	-2.11	-1.45	-4.85	-3.45	-4.79	-5.42	-7.57	-8.11	-7.46	-7.2	-9.3	-3.52	-2.18	2.39
Basic EPS from Cont Ops	-1.36	-2.11	-1.45	-4.85	-3.45	-4.79	-5.42	-7.57	-8.11	-7.46	-7.2	-9.3	-3.52	-2.18	2.39
Diluted EPS, GAAP	-1.36	-2.11	-1.45	-4.85	-3.45	-4.79	-5.42	-7.57	-8.11	-7.46	-7.2	-9.3	-3.52	-2.18	2.33
Diluted EPS from Cont Ops	-1.36	-2.11	-1.45	-4.85	-3.45	-4.79	-5.42	-7.57	-8.11	-7.46	-7.2	-9.3	-3.52	-2.18	2.33
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2.05	-2.3	-1.12	-2.23	-2.25	-3.59	-4.23	-5.59	-2.55	-5.35	-5.42	-4.45	0.83	-0.07	4
Free Cash Flow per Basic Share	-2.08	-2.47	-1.18	-2.35	-2.41	-4.35	-5.38	-6.85	-3.83	-5.96	-6.06	-5.04	0.34	-0.33	3.55
Cash & Equivalents per Share	3.45	2.44	3.99	9.38	12.86	7.32	18.67	10.78	14.06	16.3	20.56	18.02	19.53	21.11	22.2
Book Value per Share	-9.45	-10.07	-9.68	-12.87	-14.83	-19.35	-23.71	-28.23	-34.1	-39.87	-45.9	-53.97	-56.11	-57.08	-51.15
Tangible Book Value per Share	2.78	2.67	4.39	12.6	15.06	10.75	19.51	12.94	13.17	8.84	4.97	-1.3	-1.77	0.53	6.02

Alnylam Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)